WooGene B&G Co., Ltd.

As of March 31, 2026, WooGene B&G Co., Ltd. carries a market capitalization of 19.99B, placing it among publicly traded companies globally. Its enterprise value stands at 70.37B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, WooGene B&G Co., Ltd. has 6.93M shares outstanding.

These figures are as of March 31, 2026. The price-to-sales ratio is 0.37, and the price-to-book ratio stands at 0.65.

As of March 31, 2026, WooGene B&G Co., Ltd. trades at an EV/EBITDA multiple of 14.62 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.29 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 117.16 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 70.37B versus a market cap of 19.99B, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, WooGene B&G Co., Ltd. maintains a current ratio of 1.29, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 46.32, indicating elevated leverage, while an interest coverage ratio of 1.66 demonstrates limited ability to service its debt obligations.

Over the twelve months ended March 31, 2026, WooGene B&G Co., Ltd. posted a negative return on equity (ROE) of -7.37, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -1.97, reflecting losses generated across the asset base. The company generates approximately 544.76M in revenue per employee across its workforce of 100.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.23 indicates how many times WooGene B&G Co., Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2026, WooGene B&G Co., Ltd. recorded 2.33B in income tax expense. The company reported a pretax loss of -1.56B and -2.14B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 23, 2026, WooGene B&G Co., Ltd.'s stock has declined approximately 21.55% over the past 52 weeks. The 50-day moving average sits at 2,692.90, while the 200-day moving average is 2,909.13.

Over the twelve months ended March 31, 2026, WooGene B&G Co., Ltd. generated 54.75B in revenue and converted that into -2.14B in net income, yielding earnings per share of -561.18. EBITDA reached 4.81B, while operating income came in at 600.65M.

As of March 31, 2026, WooGene B&G Co., Ltd. holds 12.33B in cash and equivalents against 29.56B in total debt, resulting in a net debt position of 17.85B. Total book value stands at 30.68B, with working capital of 7.81B providing operational flexibility.

WooGene B&G Co., Ltd. produced 3.88B in operating cash flow over the twelve months ended March 31, 2026. After subtracting -2.58B in capital expenditures, free cash flow totaled 1.30B - equivalent to 187.10 per share.

Over the twelve months ended March 31, 2026, WooGene B&G Co., Ltd. posted a gross margin of 30.62, reflecting its pricing power and cost economics. The operating margin of 1.10 and net profit margin of -3.90 provide insight into operational efficiency.

These figures cover the twelve months ended March 31, 2026. Free cash flow yield stands at 6.49, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 14.96, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to WooGene B&G Co., Ltd. shareholders.

WooGene B&G Co., Ltd.'s most recent stock split took place on June 12, 2026 with a 5:6 split ratio.

As of March 31, 2026, WooGene B&G Co., Ltd. has an Altman Z-Score of 0.76, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.